BioInvent and ThromboGenics have initiated the enrollment of second cohort of patients for their phase-II trial of TB-402. TB-402 is a novel, long acting anticoagulant for the prevention
The Quebec Superior Court also approved the previously announced Debtor-in-Possession (DIP) financing arrangement with Victoria Square Ventures Inc. for new financing in an amount of up to $3
Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit in the US Federal Court in the District of Delaware against Teva Pharmaceuticals and
Sanofi-aventis has received FDA approval for Multaq (dronedarone) 400mg tablets for patients with atrial fibrillation (AF) or atrial flutter (AFL). The FDA approval is based on five international,
MorphoSys and the University of Melbourne have entered into an agreement to cooperate on investigating new therapeutic applications for MorphoSys’s MOR103 program. MOR103, a HuCAL antibody against human
Lundbeck announces positive headline results from a dose finding clinical trial with the compound Lu AA24530. It is intended for the treatment of major depressive disorder (MDD). The
Eisai is currently focusing on three clinical development programs related to Aricept (donepezil hydrochloride), for Alzheimer’s disease. Eisai has completed a phase-III study of 23mg donepezil sustained release
GlaxoSmithKline (GSK) has acquired the branded generics business of Bristol Myers Squibb in Lebanon, Jordan, Syria, Libya and Yemen for $23.2 million. The business comprises a portfolio of
Prasco has entered into a distribution and supply agreement with Axcan for authorized generic versions of URSO 250 and URSO Forte Scored family of products. Prasco plans to
Acura and King Pharmaceuticals have announced that FDA has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox Tablets CII. Its an immediate release
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.